Track Your CD4 Count and Viral Load! Use TheBody.com's New Health Tracker!

BROWSE TOPICS IN HIV TREATMENT:

HIV Treatment: Home Page

Just Diagnosed

HIV Medications

First Steps to Treatment

HIV Drug Resistance

Switching or Stopping Treatment

Third Line/Rescue Treatment

Hepatitis C Coinfection

Women & Pregnancy

HIV Treatment for Children

Side Effects & Health Problems

Research & Experimental Drugs

HIV Treatment in the Developing World

This section is sponsored in part by:

Protease Inhibitors

Show Archived (Historical) Articles

The Basics

Protease Inhibitors in Development (April 18, 2009)
To read PDF, click here
From AIDS InfoNet
Characteristics of Protease Inhibitors (PDF) (November 3, 2008)
An excerpt from the official U.S. HIV treatment guidelines for adults and adolescents. For the full guidelines, click here (PDF).
From AIDSinfo
Protease Inhibitors (August 15, 2006)
From AIDS Treatment Data Network
New HIV Protease Inhibitors: New Options in the PI Class for Treatment-Naive Persons (Spring 2004)
To read PDF, click here
In Resolute!, from PWA Coalition Colorado
HIV 101: Antiretroviral Agents Dosing and Administration Recommendations: PIs (January 2002)
To read PDF, click here
In HEPP News, from Brown Medical School
Summary of PI Dosing and Administration Recommendations (November 2001)
In HEPP News, from Brown Medical School
Dual Protease Inhibitors Gain Ground (Spring 2001)
In Bulletin of Experimental Treatments for AIDS, from San Francisco AIDS Foundation
X-Factors (November/December 2000)
Protease inhibitors may have unexpected benefits.
In GMHC Treatment Issues, from Gay Men's Health Crisis
The Protease Inhibitors Backgrounder (December 18, 1997)
In Protease Inhibitors Backgrounder, from U.S. Food and Drug Administration
How the Protease Inhibitors Work (June 1996)
Their mechanism of action, with schematic color illustrations.
In HIV Newsline, from San Francisco General Hospital
Protease Inhibitors: Opium of the Masses? (September 2000)
In Research Initiative/Treatment Action!, from The Center for AIDS
Seeing Double: A Tale of Dual Protease Inhibitors (Spring 2001)
To read PDF, click here
In CRIA Update, from AIDS Community Research Initiative of America

The Basics

Protease Inhibitors in Development (April 18, 2009)
To read PDF, click here
From AIDS InfoNet
Characteristics of Protease Inhibitors (PDF) (November 3, 2008)
An excerpt from the official U.S. HIV treatment guidelines for adults and adolescents. For the full guidelines, click here (PDF).
From AIDSinfo
Protease Inhibitors (August 15, 2006)
From AIDS Treatment Data Network
New HIV Protease Inhibitors: New Options in the PI Class for Treatment-Naive Persons (Spring 2004)
To read PDF, click here
In Resolute!, from PWA Coalition Colorado
HIV 101: Antiretroviral Agents Dosing and Administration Recommendations: PIs (January 2002)
To read PDF, click here
In HEPP News, from Brown Medical School
Summary of PI Dosing and Administration Recommendations (November 2001)
In HEPP News, from Brown Medical School
Dual Protease Inhibitors Gain Ground (Spring 2001)
In Bulletin of Experimental Treatments for AIDS, from San Francisco AIDS Foundation
X-Factors (November/December 2000)
Protease inhibitors may have unexpected benefits.
In GMHC Treatment Issues, from Gay Men's Health Crisis
The Protease Inhibitors Backgrounder (December 18, 1997)
In Protease Inhibitors Backgrounder, from U.S. Food and Drug Administration
How the Protease Inhibitors Work (June 1996)
Their mechanism of action, with schematic color illustrations.
In HIV Newsline, from San Francisco General Hospital
Protease Inhibitors: Opium of the Masses? (September 2000)
In Research Initiative/Treatment Action!, from The Center for AIDS
Seeing Double: A Tale of Dual Protease Inhibitors (Spring 2001)
To read PDF, click here
In CRIA Update, from AIDS Community Research Initiative of America

Overview

Protease Inhibitors in Development (April 18, 2009)
To read PDF, click here
From AIDS InfoNet
Characteristics of Protease Inhibitors (PDF) (November 3, 2008)
An excerpt from the official U.S. HIV treatment guidelines for adults and adolescents. For the full guidelines, click here (PDF).
From AIDSinfo
Protease Inhibitors (August 15, 2006)
From AIDS Treatment Data Network
New HIV Protease Inhibitors: New Options in the PI Class for Treatment-Naive Persons (Spring 2004)
To read PDF, click here
In Resolute!, from PWA Coalition Colorado
HIV 101: Antiretroviral Agents Dosing and Administration Recommendations: PIs (January 2002)
To read PDF, click here
In HEPP News, from Brown Medical School
Summary of PI Dosing and Administration Recommendations (November 2001)
In HEPP News, from Brown Medical School
Dual Protease Inhibitors Gain Ground (Spring 2001)
In Bulletin of Experimental Treatments for AIDS, from San Francisco AIDS Foundation
X-Factors (November/December 2000)
Protease inhibitors may have unexpected benefits.
In GMHC Treatment Issues, from Gay Men's Health Crisis
The Protease Inhibitors Backgrounder (December 18, 1997)
In Protease Inhibitors Backgrounder, from U.S. Food and Drug Administration
How the Protease Inhibitors Work (June 1996)
Their mechanism of action, with schematic color illustrations.
In HIV Newsline, from San Francisco General Hospital
Protease Inhibitors: Opium of the Masses? (September 2000)
In Research Initiative/Treatment Action!, from The Center for AIDS
Seeing Double: A Tale of Dual Protease Inhibitors (Spring 2001)
To read PDF, click here
In CRIA Update, from AIDS Community Research Initiative of America

The Body is a service of Body Health Resources Corporation, 250 West 57th Street, New York, NY 10107. The Body and its logos are trademarks of Body Health Resources Corporation, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.